{"id":"https://openalex.org/W2163363783","doi":"https://doi.org/10.1111/j.1601-5215.2012.00675.x","title":"The clinical antidepressant effect of exogenous agmatine is not reversed by parachlorophenylalanine: a pilot study","display_name":"The clinical antidepressant effect of exogenous agmatine is not reversed by parachlorophenylalanine: a pilot study","alternate_titles":[],"publication_year":2012,"publication_date":"2012-07-24","ids":{"openalex":"https://openalex.org/W2163363783","doi":"https://doi.org/10.1111/j.1601-5215.2012.00675.x","mag":"2163363783","pmid":"https://pubmed.ncbi.nlm.nih.gov/25287313"},"language":"en","primary_location":{"id":"doi:10.1111/j.1601-5215.2012.00675.x","doi":"https://doi.org/10.1111/j.1601-5215.2012.00675.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1601-5215.2012.00675.x","pdf_url":null,"source":{"id":"https://openalex.org/S173281865","display_name":"Acta Neuropsychiatrica","issn_l":"0924-2708","issn":["0924-2708","1601-5215"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Neuropsychiatrica","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2163363783"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018548930","display_name":"Baron Shopsin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Baron Shopsin","raw_affiliation_strings":["1 Former Chief, Unit for The Study and Treatment of Affective, Disorders, & Lithium Clinic, Neuropsychopharmacology Research Section, Department of Psychiatry, NYU Medical Center, and Associate Professor of Psychiatry, NYU School of Medicine, USA","Former Chief, Unit for The Study and Treatment of Affective, Disorders, & Lithium Clinic, Neuropsychopharmacology Research Section, Department of Psychiatry, NYU Medical Center, and Associate Professor of Psychiatry, NYU School of Medicine, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1 Former Chief, Unit for The Study and Treatment of Affective, Disorders, & Lithium Clinic, Neuropsychopharmacology Research Section, Department of Psychiatry, NYU Medical Center, and Associate Professor of Psychiatry, NYU School of Medicine, USA","institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I57206974"]},{"raw_affiliation_string":"Former Chief, Unit for The Study and Treatment of Affective, Disorders, & Lithium Clinic, Neuropsychopharmacology Research Section, Department of Psychiatry, NYU Medical Center, and Associate Professor of Psychiatry, NYU School of Medicine, USA","institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I57206974"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5018548930"],"corresponding_institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I57206974"],"apc_list":{"value":3550,"currency":"USD","value_usd":3550},"apc_paid":null,"fwci":2.6915,"has_fulltext":false,"cited_by_count":61,"citation_normalized_percentile":{"value":0.87768607,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"25","issue":"2","first_page":"113","last_page":"118"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":0.005400000140070915,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/agmatine","display_name":"agmatine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/p-chlorophenylalanine","display_name":"p-chlorophenylalanine","score":0.9890000224113464},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.8949999809265137},{"id":"https://openalex.org/keywords/antidepressant-effects","display_name":"antidepressant effects","score":0.9649999737739563},{"id":"https://openalex.org/keywords/serotonergic-mechanisms","display_name":"serotonergic mechanisms","score":0.8309999704360962},{"id":"https://openalex.org/keywords/glutamatergic-neurotransmission","display_name":"glutamatergic neurotransmission","score":0.847000002861023},{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.8629999756813049},{"id":"https://openalex.org/keywords/pharmacotherapy-of-depression","display_name":"depression pharmacotherapy","score":0.5479999780654907},{"id":"https://openalex.org/keywords/depression-relapse","display_name":"depression relapse","score":0.7049999833106995}],"concepts":[{"id":"https://openalex.org/C2781448169","wikidata":"https://www.wikidata.org/wiki/Q394317","display_name":"Agmatine","level":4,"score":0.8453018665313721},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.6694040298461914},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4339098036289215},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4220316410064697},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.24898472428321838},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.22078117728233337},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.05165755748748779},{"id":"https://openalex.org/C2777468819","wikidata":"https://www.wikidata.org/wiki/Q173670","display_name":"Arginine","level":3,"score":0.0},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1601-5215.2012.00675.x","doi":"https://doi.org/10.1111/j.1601-5215.2012.00675.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1601-5215.2012.00675.x","pdf_url":null,"source":{"id":"https://openalex.org/S173281865","display_name":"Acta Neuropsychiatrica","issn_l":"0924-2708","issn":["0924-2708","1601-5215"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Neuropsychiatrica","raw_type":"journal-article"},{"id":"pmid:25287313","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25287313","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta neuropsychiatrica","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1573525335","https://openalex.org/W1921860351","https://openalex.org/W1996981884","https://openalex.org/W2006861654","https://openalex.org/W2020962059","https://openalex.org/W2024910001","https://openalex.org/W2055610321","https://openalex.org/W2060192065","https://openalex.org/W2075225619","https://openalex.org/W2075414867","https://openalex.org/W2077982981","https://openalex.org/W2103255996","https://openalex.org/W2109334244","https://openalex.org/W2115763058","https://openalex.org/W2120945887","https://openalex.org/W2137992068","https://openalex.org/W2158452174","https://openalex.org/W2159302232","https://openalex.org/W6634570824"],"related_works":["https://openalex.org/W1988040877","https://openalex.org/W2077982981","https://openalex.org/W813135828","https://openalex.org/W2554835632","https://openalex.org/W2376825516","https://openalex.org/W2366392177","https://openalex.org/W2075225619","https://openalex.org/W2886221328","https://openalex.org/W2052511778","https://openalex.org/W2027987227"],"abstract_inverted_index":{"OBJECTIVES:":[0],"To":[1],"examine":[2,30],"and":[3,82,102,140,155,197,248],"record":[4],"the":[5,26,31,68,77,83,142,242],"clinical":[6],"antidepressant":[7,46,143,183,254],"effect":[8,144,184],"of":[9,33,55,100,114,147,185,194,229,246],"exogenous":[10,125,186],"agmatine,":[11],"an":[12],"amino":[13],"acid":[14],"derived":[15],"central":[16],"glutamaergic":[17],"modulator":[18,228],"in":[19,36,53,135,158,190,205,224],"endogenously":[20],"depressed":[21,58,118],"subjects.":[22],"It":[23],"was":[24,51,145,179,188,198],"also":[25],"author's":[27],"intention":[28],"to":[29,39,92,169,241],"effects":[32],"parachlorophenylalanine":[34,95],"(PCPA)":[35,96],"therapeutic":[37,208],"responders":[38,90],"determine":[40],"if":[41],"serotonergic":[42,214],"mechanisms":[43],"mediate":[44],"agmatine's":[45,221],"effect.":[47],"Methodology":[48],"Exogenous":[49],"agmatine":[50,126,176,187],"ingested":[52],"doses":[54,99],"2-3mg/day":[56],"by":[57,173,201,213],"subjects":[59,119,167],"with":[60,124],"Major":[61],"Depresssive":[62],"Disorder":[63],"(MDD),":[64],"clinically":[65],"assessed":[66],"using":[67],"21":[69],"item":[70],"Hamilton":[71],"Rating":[72,86],"Scale":[73,87],"for":[74,237,252],"Depression":[75],"(HAM-D),":[76],"Clinical":[78],"Global":[79],"Impression":[80],"(CGI)":[81],"Brief":[84],"Psychiatric":[85],"(BPRS).":[88],"Antidepressant":[89],"volunteered":[91],"concommittantly":[93],"ingest":[94],"at":[97],"starting":[98],"250mg/day,":[101],"increased":[103],"until":[104],"depressive":[105,171],"relapse,":[106],"mitigating":[107],"side":[108,151],"effects,":[109],"or":[110,149],"a":[111,191,234,249],"maximum":[112],"dosage":[113],"1250mg/day.":[115],"RESULTS:":[116],"Three":[117],"showing":[120],"total":[121],"illness":[122],"remission":[123],"did":[127],"not":[128,199,211],"relapse":[129,172],"after":[130,177],"concomitantly":[131],"adding":[132],"PCPA.":[133],"Effective":[134],"relieving":[136],"both":[137],"psychomotor":[138],"agitation":[139],"retardation,":[141],"free":[146],"physical":[148],"behavioural":[150],"effects:":[152],"gastrointestinal":[153],"discomfort":[154],"loose":[156],"stools":[157],"one":[159],"subject":[160],"resolved":[161],"spontaneously":[162],"within":[163],"days.":[164],"All":[165],"three":[166],"refused":[168],"risk":[170],"temporarily":[174],"stopping":[175],"PCPA":[178,202],"stopped.":[180],"CONCLUSION:":[181],"The":[182],"documented":[189],"small":[192],"number":[193],"MDD":[195],"subjects,":[196],"reversed/modified":[200],"confirming":[203],"findings":[204],"animals":[206],"that":[207],"response":[209],"is":[210],"mediated":[212],"mechanisms.":[215],"A":[216],"NAMDA":[217],"(N-methyl-D-aspartate)":[218],"receptor":[219],"antagonist,":[220],"recognized":[222],"function":[223],"brain":[225,238],"as":[226],"inhibitory":[227],"excitatory":[230],"glutamatergic":[231,244],"transmission":[232],"suggests":[233],"pivotal":[235],"role":[236],"glutamate,":[239],"contributing":[240],"ripening":[243],"basis":[245,251],"depression,":[247],"rational":[250],"future":[253],"pharmacotherapy.":[255]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2163363783","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":4},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
